Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ARDT NASDAQ:INNV NASDAQ:NAKA NASDAQ:PGNY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDTArdent Health$13.19+2.5%$12.34$10.10▼$20.72$1.88B0.3294,264 shs278,081 shsINNVInnovAge$3.79+3.8%$3.79$2.60▼$6.69$511.70M0.5216,876 shs14,696 shsNAKAKindlyMD$4.08+24.4%$9.99$0.65▼$34.77$1.53B33.961.22 million shs5.59 million shsPGNYProgyny$22.55-4.3%$22.94$13.39▼$26.76$1.94B1.331.03 million shs978,886 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDTArdent Health+2.62%+3.97%+16.85%-11.32%-32.96%INNVInnovAge+3.84%-1.04%+12.13%-5.72%-39.07%NAKAKindlyMD+24.39%-25.00%-46.39%+407,999,900.00%+407,999,900.00%PGNYProgyny-4.29%-4.73%-4.00%+4.01%-5.21%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDTArdent Health$13.19+2.5%$12.34$10.10▼$20.72$1.88B0.3294,264 shs278,081 shsINNVInnovAge$3.79+3.8%$3.79$2.60▼$6.69$511.70M0.5216,876 shs14,696 shsNAKAKindlyMD$4.08+24.4%$9.99$0.65▼$34.77$1.53B33.961.22 million shs5.59 million shsPGNYProgyny$22.55-4.3%$22.94$13.39▼$26.76$1.94B1.331.03 million shs978,886 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDTArdent Health+2.62%+3.97%+16.85%-11.32%-32.96%INNVInnovAge+3.84%-1.04%+12.13%-5.72%-39.07%NAKAKindlyMD+24.39%-25.00%-46.39%+407,999,900.00%+407,999,900.00%PGNYProgyny-4.29%-4.73%-4.00%+4.01%-5.21%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARDTArdent Health 2.70Moderate Buy$19.5648.33% UpsideINNVInnovAge 1.50Reduce$5.0031.93% UpsideNAKAKindlyMD 3.00Buy$8.0096.08% UpsidePGNYProgyny 2.73Moderate Buy$25.3012.20% UpsideCurrent Analyst Ratings BreakdownLatest INNV, PGNY, NAKA, and ARDT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/3/2025NAKAKindlyMDMaxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$8.008/26/2025PGNYProgynyJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$23.00 ➝ $25.008/20/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$21.00 ➝ $23.008/11/2025ARDTArdent HealthJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$18.00 ➝ $15.008/8/2025PGNYProgynyRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$28.008/8/2025PGNYProgynyCantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$26.00 ➝ $28.008/7/2025ARDTArdent HealthKeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$24.00 ➝ $20.007/17/2025PGNYProgynyTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$24.00 ➝ $27.007/16/2025ARDTArdent HealthBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeNeutral ➝ Underperform$15.50 ➝ $14.607/8/2025PGNYProgynyLeerink PartnrsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy7/8/2025PGNYProgynyLeerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$28.00(Data available from 9/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARDTArdent Health$5.97B0.32$2.54 per share5.19$10.66 per share1.24INNVInnovAge$763.85M0.67N/AN/A$2.04 per share1.86NAKAKindlyMD$2.72M564.18N/AN/A$0.43 per share9.49PGNYProgyny$1.24B1.56$0.35 per share65.34$4.96 per share4.55Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARDTArdent Health$210.34M$1.817.296.735.824.11%16.66%5.18%11/5/2025 (Estimated)INNVInnovAge-$21.34M-$0.23N/A63.17N/A-3.75%-11.91%-5.85%9/9/2025 (Estimated)NAKAKindlyMD-$3.62M-$0.86N/A∞N/A-244.00%-131.09%-106.04%N/APGNYProgyny$54.34M$0.5938.2234.691.844.28%10.69%7.12%11/11/2025 (Estimated)Latest INNV, PGNY, NAKA, and ARDT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/9/2025Q4 2025INNVInnovAge-$0.02N/AN/AN/A$219.80 millionN/A8/7/2025Q2 2025PGNYProgyny$0.42$0.19-$0.23$0.19$315.70 million$332.87 million8/5/2025Q2 2025ARDTArdent Health$0.30$0.52+$0.22$0.52$1.54 billion$1.65 billion8/5/2025Q2 2025NAKAKindlyMDN/A-$0.34N/A-$0.35N/A$0.41 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARDTArdent HealthN/AN/AN/AN/AN/AINNVInnovAgeN/AN/AN/AN/AN/ANAKAKindlyMDN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARDTArdent Health0.662.132.00INNVInnovAge0.040.780.78NAKAKindlyMDN/A13.0013.00PGNYProgynyN/A2.702.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARDTArdent HealthN/AINNVInnovAge12.26%NAKAKindlyMDN/APGNYProgyny94.93%Insider OwnershipCompanyInsider OwnershipARDTArdent Health1.70%INNVInnovAge1.40%NAKAKindlyMD40.79%PGNYProgyny9.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARDTArdent Health24,900143.11 million140.67 millionOptionableINNVInnovAge2,350135.01 million133.12 millionOptionableNAKAKindlyMDN/A376.12 million222.70 millionN/APGNYProgyny31085.98 million77.90 millionOptionableINNV, PGNY, NAKA, and ARDT HeadlinesRecent News About These CompaniesWhy Progyny (PGNY) Stock Is Trading Lower TodaySeptember 6 at 3:22 PM | msn.comProgyny (NASDAQ:PGNY) EVP Allison Swartz Sells 599 SharesSeptember 6 at 8:45 AM | insidertrades.comGraham Capital Management L.P. Takes $1.02 Million Position in Progyny, Inc. $PGNYSeptember 6 at 5:46 AM | marketbeat.comProgyny, Inc. $PGNY Stock Position Increased by AWM Investment Company Inc.September 5 at 7:12 AM | marketbeat.comPerbak Capital Partners LLP Makes New $272,000 Investment in Progyny, Inc. $PGNYSeptember 5 at 5:56 AM | marketbeat.comProgyny (NASDAQ:PGNY) EVP Sells $55,058.08 in StockSeptember 4 at 7:11 PM | marketbeat.comProgyny (NASDAQ:PGNY) shareholders have endured a 40% loss from investing in the stock three years agoSeptember 4 at 4:24 PM | finance.yahoo.comPDT Partners LLC Increases Stock Holdings in Progyny, Inc. $PGNYSeptember 3 at 8:13 AM | marketbeat.comCaption Management LLC Sells 51,200 Shares of Progyny, Inc. $PGNYSeptember 3 at 6:29 AM | marketbeat.comTrexquant Investment LP Sells 359,213 Shares of Progyny, Inc. $PGNYSeptember 3 at 5:12 AM | marketbeat.comIeq Capital LLC Purchases 54,217 Shares of Progyny, Inc. $PGNYSeptember 3 at 4:47 AM | marketbeat.comNorthern Trust Corp Decreases Holdings in Progyny, Inc. $PGNYSeptember 3 at 3:56 AM | marketbeat.comFirst Sabrepoint Capital Management LP Reduces Holdings in Progyny, Inc. $PGNYSeptember 2, 2025 | marketbeat.comAmerican Century Companies Inc. Purchases 83,660 Shares of Progyny, Inc. $PGNYSeptember 2, 2025 | marketbeat.comSurging Earnings Estimates Signal Upside for Progyny (PGNY) StockSeptember 1, 2025 | zacks.com2 Small-Cap Stocks Worth Your Attention and 1 We Brush OffSeptember 1, 2025 | finance.yahoo.comHsbc Holdings PLC Purchases 61,416 Shares of Progyny, Inc. $PGNYAugust 30, 2025 | marketbeat.comWellington Management Group LLP Boosts Stock Position in Progyny, Inc. $PGNYAugust 29, 2025 | marketbeat.comRussell Investments Group Ltd. Boosts Stake in Progyny, Inc. $PGNYAugust 28, 2025 | marketbeat.comJPMorgan Chase & Co. Issues Positive Forecast for Progyny (NASDAQ:PGNY) Stock PriceAugust 28, 2025 | americanbankingnews.comProgyny (PGNY) Stock Trades Up, Here Is WhyAugust 27, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeINNV, PGNY, NAKA, and ARDT Company DescriptionsArdent Health NYSE:ARDT$13.19 +0.33 (+2.54%) Closing price 09/5/2025 03:59 PM EasternExtended Trading$13.58 +0.40 (+3.02%) As of 09/5/2025 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.InnovAge NASDAQ:INNV$3.79 +0.14 (+3.84%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$3.75 -0.04 (-1.06%) As of 09/5/2025 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.KindlyMD NASDAQ:NAKA$4.08 +0.80 (+24.39%) As of 09/5/2025 04:00 PM EasternKindly MD, Inc. (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. Through its focus on an embedded model of prescriber and therapist teams, KindlyMD develops patient-specific care programs with a specific mission to reduce opioid use in the patient population while successfully treating patients with effective and evidence-based non-opioid alternatives in close conjunction with behavioral therapy. Beyond its treatment of patients, KindlyMD collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The Company captures all relevant datapoints to assist and appropriately treat each individual patient. This also results in valuable data for the Company and the Company’s investors. We strive to become a source for evidence-based guidelines, data, treatment models, and education in the fight against the opioid crisis in America. Business Revenue Streams We currently earn revenue through (i) patient care services related to medical evaluation and treatment and (ii) product retail sales. Our forecasted plan is to operate across various revenue streams: (i) medical evaluation and treatment visits reimbursed by Medicare, Medicaid, and commercial insurance payers as well as self-pay services, (ii) data collection and research, (iii) education partnerships, (iv) service affiliate agreements, and (v) retail sales. Our principal executive offices are located at 5097 S 900 E, Suite 100 Salt Lake City, UT.Progyny NASDAQ:PGNY$22.55 -1.01 (-4.29%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$22.40 -0.15 (-0.67%) As of 09/5/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/01 - 09/05 Lululemon Share Price Has Plenty of Room Left to Fall Why DocuSign Could Be a SaaS Value Play After Q2 Earnings Why Hedge Fund Elliott Bet $4B on Pepsi and Sees Over 50% Upside Palantir Insider Selling: Risk Signal or Normal Activity? Advanced Micro Devices' 2026 Forecasts Are Way Too Low Salesforce Stumbles, But Investors Eye a Major Comeback Buy the Dip? GitLab’s Bullish Case Outweighs the Bears Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
